[go: up one dir, main page]

ES2337537B8 - PREPARED FOOD AND PHARMACEUTICAL COMPOSITION CONTAINING AN EMBRYO EXTRACT AND ITS RESPECTIVE USES. - Google Patents

PREPARED FOOD AND PHARMACEUTICAL COMPOSITION CONTAINING AN EMBRYO EXTRACT AND ITS RESPECTIVE USES. Download PDF

Info

Publication number
ES2337537B8
ES2337537B8 ES200800802A ES200800802A ES2337537B8 ES 2337537 B8 ES2337537 B8 ES 2337537B8 ES 200800802 A ES200800802 A ES 200800802A ES 200800802 A ES200800802 A ES 200800802A ES 2337537 B8 ES2337537 B8 ES 2337537B8
Authority
ES
Spain
Prior art keywords
pharmaceutical composition
composition containing
respective uses
embryonic
prepared food
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES200800802A
Other languages
Spanish (es)
Other versions
ES2337537A1 (en
ES2337537B2 (en
Inventor
Joan Cunill Aixela
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to ES200800802A priority Critical patent/ES2337537B8/en
Priority to PCT/EP2009/052764 priority patent/WO2009115429A1/en
Publication of ES2337537A1 publication Critical patent/ES2337537A1/en
Publication of ES2337537B2 publication Critical patent/ES2337537B2/en
Application granted granted Critical
Publication of ES2337537B8 publication Critical patent/ES2337537B8/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/08—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from eggs
    • A23L1/30—
    • A23L1/32—
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L15/00—Egg products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A61K8/982—Reproductive organs; Embryos, Eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Developmental Biology & Embryology (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Preparado alimenticio y composición farmacéutica que
contiene un extracto embrionario y sus respectivos usos. El preparado alimenticio comprende un germen embrionario en fase final de gástrula extraído de un huevo fecundado e incubado. Por otro lado, la composición farmacéutica contiene corno sustancia activa un extracto embrionario en la etapa de desarrollo embrionario final de gástrula extraído de un huevo fecundado e incubado. Dicho preparado se usa como complemento alimenticio para la prevención de la caída de pelo. Por otro lado, dicha composición farmacéutica puede ser utilizada corno medicamento para tratamientos antidegenerativos.Food preparation and pharmaceutical composition that
It contains an embryonic extract and its respective uses. The food preparation comprises an embryonic germ in the final phase of the gastrula extracted from a fertilized and incubated egg. On the other hand, the pharmaceutical composition contains as an active substance an embryonic extract at the stage of final embryonic development of the gland extracted from a fertilized and incubated egg. Said preparation is used as a food supplement for the prevention of hair loss. On the other hand, said pharmaceutical composition can be used as a medicament for antidegenerative treatments.

ES200800802A 2008-03-19 2008-03-19 PREPARED FOOD AND PHARMACEUTICAL COMPOSITION CONTAINING AN EMBRYO EXTRACT AND ITS RESPECTIVE USES. Expired - Fee Related ES2337537B8 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ES200800802A ES2337537B8 (en) 2008-03-19 2008-03-19 PREPARED FOOD AND PHARMACEUTICAL COMPOSITION CONTAINING AN EMBRYO EXTRACT AND ITS RESPECTIVE USES.
PCT/EP2009/052764 WO2009115429A1 (en) 2008-03-19 2009-03-10 Food preparation and pharmaceutical composition containing an embryonic extract

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200800802A ES2337537B8 (en) 2008-03-19 2008-03-19 PREPARED FOOD AND PHARMACEUTICAL COMPOSITION CONTAINING AN EMBRYO EXTRACT AND ITS RESPECTIVE USES.

Publications (3)

Publication Number Publication Date
ES2337537A1 ES2337537A1 (en) 2010-04-26
ES2337537B2 ES2337537B2 (en) 2011-02-02
ES2337537B8 true ES2337537B8 (en) 2011-08-01

Family

ID=40833510

Family Applications (1)

Application Number Title Priority Date Filing Date
ES200800802A Expired - Fee Related ES2337537B8 (en) 2008-03-19 2008-03-19 PREPARED FOOD AND PHARMACEUTICAL COMPOSITION CONTAINING AN EMBRYO EXTRACT AND ITS RESPECTIVE USES.

Country Status (2)

Country Link
ES (1) ES2337537B8 (en)
WO (1) WO2009115429A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR086437A1 (en) * 2011-10-13 2013-12-11 Aixela Juan Cunill PREPARED EGG WITH REGENERATING, ANALGESIC AND / OR ANTI-INFLAMMATORY PROPERTIES
ITMI20120008A1 (en) * 2012-01-04 2013-07-05 Biava Maura COMPOSITIONS WITH ANTI-NEURODEGENERATIVE ACTIVITY
ES2604552B1 (en) * 2017-01-19 2017-09-13 Liofilizados Girona, S.L. Egg preparation with anti-inflammatory and antioxidant properties

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888172A (en) * 1982-09-23 1989-12-19 Alfaceu Corporation Pharmaceutical for treating tumors and methods for making it
DE4400640A1 (en) * 1994-01-12 1995-07-13 Eftag Entstaubung Foerdertech Diagnosis and treatment of malignant tumours
IT1284571B1 (en) * 1996-09-20 1998-05-21 Adriana Carluccio ANTI-CANCER COMPOSITION CONTAINING AN EMBRYONAL OR PREGNANT UTERUS EXTRACT AS THE ACTIVE SUBSTANCE AND RELATED PROCEDURE FOR PREPARATION
CA2197050A1 (en) * 1997-02-07 1998-08-07 Morton P. Shulman Anti-cancer agents derived from fertilized incubated shell eggs
FR2778850A1 (en) * 1998-05-22 1999-11-26 Jacques Vincent Cavaille Composition for retarding aging of mammals
ITMI20021362A1 (en) * 2002-06-20 2003-12-22 Biava Pier Mario USE OF AN ANIMAL EMBRYON EXTRACT AS A NOURISHING SUBSTANCE AND DIETARY-NUTRACEUTICAL SUPPLEMENT
ITMI20051572A1 (en) * 2005-08-12 2007-02-13 Alberto Astaldi PHARMACEUTICAL COMPOSITION CONTAINING AS AN ACTIVE SUBSTANCE A PROTEIN FRACTION EXTRACTED FROM EMBRYOS OF OVIPARIANS IN THE PERIOD OF CELLULAR DIFFERENTIATION AND RELATIVE PREPARATION PROCESS
US20070275036A1 (en) * 2006-05-18 2007-11-29 Celldyne Biopharma, Llc Avian follistatin product

Also Published As

Publication number Publication date
ES2337537A1 (en) 2010-04-26
ES2337537B2 (en) 2011-02-02
WO2009115429A1 (en) 2009-09-24

Similar Documents

Publication Publication Date Title
CL2013001567A1 (en) Combinations of active ingredients comprising pyridylethylbenzamides; procedure to combat animal pests; use of the combination to treat seeds.
CL2019000575A1 (en) Amylin analogs.
AR093386A1 (en) COMPOSITION TO TREAT DIABETES OR DIABESITY INCLUDING AN OXINTOMODULIN ANALOG AND TREATMENT METHOD
CO6720961A2 (en) Imidazopyridazines substituted
MX2020005645A (en) Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation.
DOP2012000299A (en) 5-FLUORO-1H-REPLACED PIRAZOLOPIRIDINES AND ITS USE
AR090465A1 (en) SOLID FORMS OF A THIOPHOSPHORAMIDATE NUCLEOTIDE PROFARMACO
ECSP13012668A (en) 1-BENCILCICLOALQUILCARBOXÍLICOS ACIDS SUBSTITUTED AND ITS USE
MX2015011445A (en) Compounds and uses thereof for the modulation of hemoglobin.
MX383715B (en) Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
DOP2010000304A (en) COMPOSITIONS AND METHODS OF PREPARATION AND USE OF THE SAME
NI201000189A (en) SOLID MEDICINE FORMULATION WITH DELAYED RELEASE.
DOP2016000253A (en) NEW COMPOUNDS
DOP2016000102A (en) (AZA) PIRIDOPIRAZOLOPIRIMIDINONAS AND INDAZOLOPIRIMIDINONAS AND ITS USE
BR112012007798A2 (en) stable microcapsules and composition for topical application and method for preparing microcapsules
ES2429422R1 (en) Pharmaceutical composition and its use to prepare a medicine for the treatment and prevention of HIV diseases
CR20160235A (en) TIENOPIRIMIDINS AS MKNK1 AND MKNK2 INHIBITORS
CL2012002893A1 (en) Composition of at least one active ingredient of vegetable or synthetic origin thereof, or extract of plant origin containing it, in an aqueous solution, which also comprises lecithin as an encapsulating agent; medicine that understands it; method for its preparation; and its use to treat intestinal parasitosis.
ES2337537B8 (en) PREPARED FOOD AND PHARMACEUTICAL COMPOSITION CONTAINING AN EMBRYO EXTRACT AND ITS RESPECTIVE USES.
AR075301A1 (en) COMPOSITION AND METHOD FOR CONTROLLING PLANT DISEASES
BR112014013374A8 (en) Acamprosate Pills and Uses of Acamprosate
AR086000A1 (en) COMPOSITION FOR HAIR CARE
CL2014000903A1 (en) Egg preparation comprising a mixture of yolk and white extracted from a fertilized egg with regenerative, analgesic and / or anti-inflammatory properties; procedure for preparing said preparation; functional food; dietary supplement; cosmetic composition; And its use.
BR112013027775A2 (en) skin whitening method
PE20141675A1 (en) COMPOSITION AND METHODS OF PHYTONUTRIENTS FOR METABOLIC PROGRAMMING EFFECTS

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20100426

Kind code of ref document: A1

FG2A Definitive protection

Ref document number: 2337537

Country of ref document: ES

Kind code of ref document: B2

Effective date: 20110121

FD2A Announcement of lapse in spain

Effective date: 20180924